Tumor delivery of antisense oligomer using trastuzumab within a streptavidin nanoparticle

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 12, 2009, Pages 1977-1986

  Wang, Yi ^a   Liu, Xinrong ^a   Chen, Ling ^a   Cheng, Dengfeng ^a   Rusckowski, Mary ^a   Hnatowich, Donald J ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antisense; MORF oligomer; Nanoparticle; Streptavidin; Trastuzumab

Indexed keywords

DYE; NANOPARTICLE; OLIGOMER; STREPTAVIDIN; TECHNETIUM 99M; TRASTUZUMAB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; FLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; RADIATION DETECTION; WHOLE BODY IMAGING;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL TRANSPORT; BIOTIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DRUG CARRIERS; FEMALE; HUMANS; INTRACELLULAR SPACE; MICE; MORPHOLINES; NANOPARTICLES; RECEPTOR, ERBB-2; STREPTAVIDIN;

EID: 71849086207     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1201-2     Document Type: Article

References (35)

1. K Nakamura Y Wang X Liu A Kubo DJ Hnatowich 2007 Cationic transfectors increase accumulation in cultured tumor cells of radiolabeled antisense DNAs without entrapment Cancer Biother Radiopharm 22 629 635 10.1089/cbr.2006.374 1:CAS:528:DC%2BD2sXht1GrsLvP 17979565 (Pubitemid 350058998)
2. C Zhang N Tang X Liu W Liang W Xu VP Torchilin 2006 siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene J Control Release 112 229 239 10.1016/j.jconrel.2006.01.022 1:CAS:528: DC%2BD28XktVWnsLs%3D 16545478
3. M Breunig C Hozsa U Lungwitz K Watanabe I Umeda H Kato, et al. 2008 Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo J Control Release 130 57 63 10.1016/j.jconrel.2008.05.016 1:CAS:528:DC%2BD1cXps1ahurc%3D 18599144
4. SH Kim JH Jeong SH Lee SW Kim TG Park 2008 Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer J Control Release 129 107 116 10.1016/j.jconrel.2008.03.008 1:CAS:528:DC%2BD1cXnsFaltbo%3D 18486981
5. AR de Fougerolles 2008 Delivery vehicles for small interfering RNA in vivo Hum Gene Ther 19 125 132 10.1089/hum.2008.928 18257677 (Pubitemid 351278372)
6. M Liu RF Wang CL Zhang P Yan MM Yu LJ Di, et al. 2007 Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors J Nucl Med 48 2028 2036 10.2967/jnumed.107.042622 1:CAS:528:DC%2BD1cXnvFSmsA%3D%3D 18006621 (Pubitemid 350232314)
7. K Nakamura C Fan G Liu S Gupta J He S Dou, et al. 2004 Evidence of antisense tumor targeting in mice Bioconjug Chem 15 1475 1480 10.1021/bc0499073 1:CAS:528:DC%2BD2cXotVOmu7s%3D 15546217 (Pubitemid 39552039)
8. N Liu H Ding JL Vanderheyden Z Zhu Y Zhang 2007 Radiolabeling small RNA with technetium-99 m for visualizing cellular delivery and mouse biodistribution Nucl Med Biol 34 399 404 10.1016/j.nucmedbio.2007.02.006 1:CAS:528: DC%2BD2sXlt1aiu7c%3D 17499729 (Pubitemid 46710412)
9. Y Wang K Nakamura X Liu N Kitamura A Kubo DJ Hnatowich 2007 Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture Bioconjug Chem 18 1338 1343 10.1021/bc070032c 1:CAS:528:DC%2BD2sXntFKqtrg%3D 17605463 (Pubitemid 47122658)
10. K Nakamura Y Wang X Liu A Kubo DJ Hnatowich 2007 Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker J Nucl Med 48 1845 1852 10.2967/jnumed.106.039339 1:CAS:528:DC%2BD2sXhsVSitrzJ 17978353 (Pubitemid 350099331)
11. EH Romond EA Perez J Bryant VJ Suman CE Geyer Jr NE Davidson, et al. 2005 Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673 1684 10.1056/NEJMoa052122 1:CAS:528:DC%2BD2MXhtFansr3F 16236738 (Pubitemid 41464706)
12. R Nahta FJ Esteva 2003 HER-2-targeted therapy: lessons learned and future directions Clin Cancer Res 9 5078 5084 1:CAS:528:DC%2BD3sXovVOgtb4%3D 14613984
13. MJ Piccart-Gebhart M Procter B Leyland-Jones A Goldhirsch M Untch I Smith, et al. 2005 Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 1659 1672 10.1056/NEJMoa052306 1:CAS:528:DC%2BD2MXhtFansr3L 16236737 (Pubitemid 41464705)
14. J Bange E Zwick A Ullrich 2001 Molecular targets for breast cancer therapy and prevention Nat Med 7 548 552 10.1038/87872 1:CAS:528: DC%2BD3MXjsVakuro%3D 11329054 (Pubitemid 32448320)
15. PJ Perik MN Lub-De Hooge JA Gietema WT van der Graaf MA de Korte S Jonkman, et al. 2006 Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer J Clin Oncol 24 2276 2282 10.1200/JCO.2005.03.8448 1:CAS:528: DC%2BD28XlvV2ksLc%3D 16710024 (Pubitemid 46630657)
16. L Sampath S Kwon S Ke W Wang R Schiff ME Mawad, et al. 2007 Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer J Nucl Med 48 1501 1510 10.2967/jnumed.107.042234 1:CAS:528:DC%2BD2sXhtFGgsLjE 17785729 (Pubitemid 47397400)
17. S Palm RM Enmon Jr C Matei KS Kolbert S Xu PB Zanzonico, et al. 2003 Pharmacokinetics and biodistribution of (86)Y-trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI J Nucl Med 44 1148 1155 1:CAS:528:DC%2BD3sXmtF2msbg%3D 12843231
18. H Kobayashi K Shirakawa S Kawamoto T Saga N Sato A Hiraga, et al. 2002 Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256) Cancer Res 62 860 866 1:CAS:528:DC%2BD38Xht1Kqsr4%3D 11830544
19. HS Cho K Mason KX Ramyar AM Stanley SB Gabelli DW Denney Jr, et al. 2003 Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab Nature 421 756 760 10.1038/nature01392 1:CAS:528: DC%2BD3sXhsV2rtrw%3D 12610629 (Pubitemid 36227628)
20. R Mandler H Kobayashi ER Hinson MW Brechbiel TA Waldmann 2004 Herceptin-geldanamycin immunoconjugates: pharmacokinetics, biodistribution, and enhanced antitumor activity Cancer Res 64 1460 1467 10.1158/0008-5472.CAN-03- 2485 1:CAS:528:DC%2BD2cXhtleit7Y%3D 14973048 (Pubitemid 38235617)
21. KL van Golen ZF Wu XT Qiao LW Bao SD Merajver 2000 RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype Cancer Res 60 5832 5838 11059780
22. EA Clark TR Golub ES Lander RO Hynes 2000 Genomic analysis of metastasis reveals an essential role for RhoC Nature 406 532 535 10.1038/35020106 1:CAS:528:DC%2BD3cXmtFensbo%3D 10952316 (Pubitemid 30625739)
23. KL van Golen LW Bao Q Pan FR Miller ZF Wu SD Merajver 2002 Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer Clin Exp Metastasis 19 301 311 10.1023/A:1015518114931 12090470 (Pubitemid 34606755)
24. A Hakem O Sanchez-Sweatman A You-Ten G Duncan A Wakeham R Khokha, et al. 2005 RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis Genes Dev 19 1974 1979 10.1101/gad.1310805 1:CAS:528: DC%2BD2MXhtVSlurjL 16107613 (Pubitemid 41247955)
25. CG Kleer KA Griffith MS Sabel G Gallagher KL van Golen ZF Wu, et al. 2005 RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast Breast Cancer Res Treat 93 101 110 10.1007/s10549-005-4170-6 1:CAS:528:DC%2BD2MXhtVektLfL 16187229 (Pubitemid 41396771)
26. CG Kleer KL van Golen Y Zhang ZF Wu MA Rubin SD Merajver 2002 Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability Am J Pathol 160 579 584 1:CAS:528:DC%2BD38XitVCktrg%3D 11839578
27. Y Wang X Liu DJ Hnatowich 2007 An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with (99m)Tc at room temperature Nat Protoc 2 972 978 10.1038/nprot.2007.144 1:CAS:528:DC%2BD2sXhtFGnurzM 17446896 (Pubitemid 46745593)
28. Y Wang G Liu DJ Hnatowich 2006 Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules Nat Protoc 1 1477 1480 10.1038/nprot.2006.262 1:CAS:528:DC%2BD28Xht1eitL7F 17406438
29. X Liu Y Wang K Nakamura S Kawauchi A Akalin D Cheng, et al. 2009 Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In J Nucl Med 50 582 590 10.2967/jnumed.108.056366 1:CAS:528:DC%2BD1MXltVOgtro%3D 19289423
30. VB Kandimalla NS Neeta NG Karanth MS Thakur KR Roshini BE Rani, et al. 2004 Regeneration of ethyl parathion antibodies for repeated use in immunosensor: a study on dissociation of antigens from antibodies Biosens Bioelectron 20 903 906 10.1016/j.bios.2004.03.027 1:CAS:528:DC%2BD2cXpt1WhtLg%3D 15522608 (Pubitemid 39441272)
31. G Liu S Dou D Yin S Squires X Liu Y Wang, et al. 2007 A novel pretargeting method for measuring antibody internalization in tumor cells Cancer Biother Radiopharm 22 33 39 10.1089/cbr.2006.339 17461727 (Pubitemid 46697364)
32. S Etienne-Manneville A Hall 2002 Rho GTPases in cell biology Nature 420 629 635 10.1038/nature01148 1:CAS:528:DC%2BD38XpsVSitbw%3D 12478284 (Pubitemid 36764489)
33. X Liu Y Wang K Nakamura A Kubo DJ Hnatowich 2008 Cell studies of a three-component antisense MORF/tat/Herceptin nanoparticle designed for improved tumor delivery Cancer Gene Ther 15 126 132 10.1038/sj.cgt.7701111 1:CAS:528:DC%2BD1cXmsFWnsA%3D%3D 18084241
34. G Liu K Mang'era N Liu S Gupta M Rusckowski DJ Hnatowich 2002 Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog J Nucl Med 43 384 391 1:CAS:528:DC%2BD38XjvVKnu7k%3D 11884499
35. G Liu J He S Dou S Gupta JL Vanderheyden M Rusckowski, et al. 2004 Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake Eur J Nucl Med Mol Imaging 31 417 424 10.1007/s00259-003-1393-9 1:CAS:528:DC%2BD2cXhtlygtLs%3D 14691611 (Pubitemid 38314087)